Abstract
Extracellular phospholipase A2 (PLA2) activity was detected in exudate from rat carrageenan-induced pleurisy using [3H]oleic acid-labeledEscherichia coli as substrate. Both exudate volume and PLA2 activity increased up to 24 h after carrageenin injection. Specific absorption of this activity by anti-group II PLA2 (PLA2-II) antibody indicated that the PLA2 activity in the pleural exudate was PLA2-II. Thielocin Alβ, a novel type of PLA2 inhibitor from fungi, inhibited this PLA2-II activity in a dose-dependent manner (IC50=0.32μM). Thielocin A1β correspondingly reduced both exudate volume and PLA2-II activity in the exudate in a dose-dependent manner when coinjected with carrageenan. The exudate volume was also significantly decreased when indomethacin, a cyclooxygenase inhibitor, or dexamethasone, a steroidal antiinflammatory drug, was coinjected with carrageenan. However, neither indomethacin nor dexamethasone could significantly attenuate the PLA2-II activity in exudate In addition, indomethacin and dexamethasone significantly reduced the levels of PGE2 in the exudate. However, thielocin A1β had no effect on the PGE2 content in the exudate. These results suggest that thielocin A1β shows antiinflammatory activity due to inhibition of PLA2-II and offer evidence for the significance of PLA21I in the propagation of inflammatory processes.
Similar content being viewed by others
References
Dennis, E. A. Phospholipases. 1983.In The Enzymes, Vol. 16. P. D. Boyer, editor. Academic Press, New York. 307–353.
Van Den Bosch, H. 1980. Intracellular phospholipase A.Biochim. Biophys. Acta 604:191–246.
Heinrikson, R. L., E. T. Krueger, andP. S. Keim. 1977. Amino acid sequence of phospholipase A2 —α from the venom ofCrotalus adamanteus. A new classification of phospholipase A2 based upon structural determinants.J. Biol. Chem. 252:4913–4921.
Ohara, O., M. Tamaki, E. Nakamura, Y. Tsuruta, Y. Fujii, M. Shin, H. Teraoka, andM. Okamoto. 1986. Dog and rat pancreatic phospholipase A2: Complete amino acid sequences deduced from complementary DNAs.J. Biochem. 99:733–739.
Franson, R., R. Dobrow, J. Weiss, P. Elsbach, andW. B. Weglicki. 1978. Isolation and characterization of a phospholipase A2 from an inflammatory exudate.J. Lipid Res. 19:18–23.
Chang, H. W., I. Kudo, M. Tomita, andK. Inoue. 1987. Purification and characterization of extracellular phospholipase A2 from peritoneal cavity of caseinate-treated rat.J. Biochem. 102:147–154.
Pruzanski, W., P. Vadak, E. Stefanski, andM. B. Urowitz. 1985. Phospholipase A2 activity in sera and synovial fluids in rheumatoid arthritis and osteoarthritis. Its possible role as a proinflammatory enzyme.J. Rheumatol. 12:211–216.
Nakano, T., O. Ohara, H. Teraoka, andH. Arita. 1990. Group II phospholipase A2 mRNA synthesis is stimulated by two distinct mechanisms in rat vascular smooth muscle cells.FEBS Lett. 261:171–174.
Oka, S., andH. Arita. 1991. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression.J. Biol. Chem. 266:9956–9960.
Bomalaski, J. S., P. Lawton, andJ. L. Browing. 1991. Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints.J. Immunol. 146:3904–3910.
Hayakawa, M., I. Kudo, M. Tomita, S. Nojima, andK. Inoue. 1988. The primary structure of rat platelet phospholipase A2.J. Biochem. 104:767–772.
Yoshida, T., S. Nakamoto, R. Sakazaki, K. Matsumoto, Y. Terui, T. Sato, H. Arita, S. Matsutani, K. Inoue, andI. Kudo. 1991. Thielocin A1α and A1β, Novel phospholipase A2 inhibitors from ascomycetes.J. Antibiot. 44:1467–1470.
Tanaka, K., S. Matsutani, K. Matsumoto, andT. Yoshida. 1992. A novel type of phospholipase A2 inhibitor, thielocin A1β, and mechanism of action.J. Antibiot. 45:1071–1078.
Ono, T., H. Tojo, K. Inoue, T. Kagamiyama, T. Yamano, andM. Okamoto. 1984. Rat pancreatic phospholipase A2: Purification, characterization, and N-terminal amino acid sequence.J. Biochem. 96:785–792.
Tanaka, K., H. Itazaki, andT. Yoshida. 1992. Cinatrins, a novel family of phospholipase A2 inhibitors. II. Biological activities.J. Antibiot. 45:50–55.
Davidson, F. F., E. A. Dennis, M. Powell, andJ. R. Glenney, Jr. 1987. Inhibition of phospholipase A2 by “lipocortins” and calpactins. An effect of binding to substrate phospholipids.J. Biol. Chem. 262:1698–1705.
Harada, Y., K. Tanaka, Y. Uchida, A. Ueno, S. Oh-Ishi, K. Yamashita, M. Ishibashi, H. Miyazaki, andM. Katori. 1982. Changes in the levels of prostaglandins and thromboxane and their roles in the accumulation of exudate in rat carrageenan-induced pleurisy. A profile analysis using gas chromatography-mass spectrometry.Prostaglandins 23:881–895.
Dole, V. P., andH. Meinertz. 1960. Microdetermination of long-chain fatty acids in plasma and tissues.J. Biol. Chem. 235:2595–2599.
Natori, Y., K. Karasawa, H. Arai, Y. Tamori-Natori, andS. Nojima. 1983. Partial purification and properties of phospholipase A2 from rat liver mitochondria.J. Biochem. 93:631–637.
Powell, W. S. 1980. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica.Prostaglandins 20:947–957.
Lowry, O. H., N. J. Rosebrough, A. L. Farr, andR. J. Randall. 1951. Protein measurement with the Folin phenol reagent.J. Biol Chem. 193:265–275.
Nakano, T., andH. Arita. 1990. Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid.FEBS Lett. 273:23–26.
Vishwanath, B. S., A. A. Fawzy, andR. C. Franson. 1988. Edema-inducing activity of phospholipase A2 purified from human synovial fluid and inhibition by aristolochic acid.Inflammation 12:549–561.
Marshall, L. A., J. Y. Chang, W. Calhoun, J. Yu, andR. P. Carlson. 1989. Preliminary studies on phospholipase A2-induced mouse paw edema as a model to evaluate antiinflammatory agents.J. Cell. Biochem. 40:147–155.
Cirino, G., S. H. Peers, J. L. Wallace, andR. J. Flower. 1989. A study of phospholipase A2-induced oedema in rat paw.Eur. J. Pharmacol. 166:505–510.
Kramer, R. M., C. Hession, B. Johansen, G. Hayes, P. McGray, E. P. Chow, R. Tizard, andR. B. Pepinsky. 1989. Structure and properties of a human non-pancreatic phospholipase A2.J. Biol. Chem. 264:5768–5775.
Clark, J. D., L. L. Lin, R. W. Kriz, C. S. Ramesha, L. A. Sultzman, A. Y. Lin, N. Milona, andJ. L. Knopf. 1991. A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAP.Cell 65:1043–1051.
Glatt, M., P. Dieppe, andD. Willoughby. 1979. Crystal-induced inflammation, enzyme release and the effects of drugs in the pleural space.J. Rheumatol. 6:251–258.
Doherty, N. S., andB. V. Robinson. 1976. Some biological and pharmacological properties of inflammatory exudates.J. Pharm. Pharmacol. 28:859–864.
Murakami, M., I. Kudo, andK. Inoue. 1991. Eicosanoid generation from antigen-primed mast cells by extracellular mammalian 14-kDa group II phospholipase A2.FEBS Lett. 294:247–251.
Vinegar, R., J. F. Truax, J. L. Selph, andF. A. Voelker. 1982. Pathway of onset, development, and decay of carrageenan pleurisy in the rat.Fed. Proc. 41:2588–2595.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tanaka, K., Kato, T., Matsumoto, K. et al. Antiinflammatory action of thielocin A1β, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy. Inflammation 17, 107–119 (1993). https://doi.org/10.1007/BF00916098
Issue Date:
DOI: https://doi.org/10.1007/BF00916098